Crystalline Solid forms of compounds benzodiazol pyrrolidin-3-yl - - - - naftalen diazol pyrrolidin-3-yl replaced, inhibitors of the nonstructural Protein 5A (NS5A) of hepatitis C virus (HCV)； and a Pharmaceutical composition containing gel Capsule.
ZHONG, MIN,LI, LEPING,LORIMER, KEITH,MUCHNIK, ANNA
申请号：
CL2014002138
公开号：
CL2014002138A1
申请日:
2014.08.12
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
This invention relates to: a) compounds and salts thereof that, inter alia, inhibit HCV； (b) intermediates useful for the preparation of such compounds and salts； (c) composition comprising such compounds and salts； (d) methods for preparing such intermediates, compounds, salts, and composition； (e) method of use of such compounds, salts, and compositions； and (f) kits comprising such compounds, salts, and composition.FORMAS SÓLIDAS CRISTALINAS DE COMPUESTOS DERIVADOS DE BENZOIMIDAZOL-NAFTALEN-IMIDAZOL SUSTITUIDOS, INHIBIDORES DE LA PROTEINA NO ESTRUCTURAL 5A (NS5A) DEL VIRUS DE LA HEPATITIS C (HCV)； Y COMPOSICIÓN FARMACÉUTICA Y CÁPSULA DE GEL QUE LAS COMPRENDE.
